Vimta Labs Q1 FY27 Income Up 13.7% YoY to ₹1,129 Mn

Vimta Labs Limited announced its unaudited financial results for the first quarter ended June 30, 2026. Total income for Q1 FY27 stood at ₹1,129 million, marking a 13.7% year-on-year increase. EBITDA margins were reported at 36.4%, and PAT margins at 18.6%. The company highlighted strong performance in Pharmaceutical Research and Testing Services, while the Food Testing division navigated global uncertainties through domestic market penetration. Vimta Labs also successfully completed a regulatory audit from Ukraine and commenced operations in Biologics contract research and development services (CRADS). The Managing Director expressed optimism about future prospects.